227 related articles for article (PubMed ID: 36602290)
1. Cancer stem cell-immune cell collusion in immunotherapy.
Wang YY; Wang WD; Sun ZJ
Int J Cancer; 2023 Aug; 153(4):694-708. PubMed ID: 36602290
[TBL] [Abstract][Full Text] [Related]
2. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
[TBL] [Abstract][Full Text] [Related]
4. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
5. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
6. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
[TBL] [Abstract][Full Text] [Related]
7. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
[TBL] [Abstract][Full Text] [Related]
8. An emerging role for cellular crosstalk in the cancer stem cell niche.
Oshimori N; Guo Y; Taniguchi S
J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of targeting MDSCs in tumor microenvironment.
Sui H; Dongye S; Liu X; Xu X; Wang L; Jin CQ; Yao M; Gong Z; Jiang D; Zhang K; Liu Y; Liu H; Jiang G; Su Y
Front Immunol; 2022; 13():990463. PubMed ID: 36131911
[TBL] [Abstract][Full Text] [Related]
10. The STAT family: Key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment.
Zhu M; Li S; Cao X; Rashid K; Liu T
Semin Cancer Biol; 2023 Jan; 88():18-31. PubMed ID: 36410636
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy.
Rouzbahani E; Majidpoor J; Najafi S; Mortezaee K
Biomed Pharmacother; 2022 Dec; 156():113906. PubMed ID: 36306594
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
14. Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.
Khosravi N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Shahgoli VK; Hemmat N; Safarzadeh E; Baradaran B
Life Sci; 2020 Sep; 256():118005. PubMed ID: 32593711
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
Ma Y; Lv H; Xing F; Xiang W; Wu Z; Feng Q; Wang H; Yang W
Front Med; 2024 Jun; 18(3):430-445. PubMed ID: 38600350
[TBL] [Abstract][Full Text] [Related]
16. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis.
Singh D; Khan MA; Siddique HR
Biochem Pharmacol; 2022 Apr; 198():114955. PubMed ID: 35181312
[TBL] [Abstract][Full Text] [Related]
17. RNA N
Zhang Z; Zhang C; Luo Y; Zhang G; Wu P; Sun N; He J
Clin Transl Med; 2021 Sep; 11(9):e525. PubMed ID: 34586737
[TBL] [Abstract][Full Text] [Related]
18. Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy.
Gu Y; Zhang Z; Ten Dijke P
Cell Mol Immunol; 2023 Apr; 20(4):318-340. PubMed ID: 36823234
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment.
Wu B; Shi X; Jiang M; Liu H
Mol Cancer; 2023 Feb; 22(1):38. PubMed ID: 36810098
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell-immune cell crosstalk in tumour progression.
Bayik D; Lathia JD
Nat Rev Cancer; 2021 Aug; 21(8):526-536. PubMed ID: 34103704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
